SC
IMPV

Sessa Capital’s Imperva, Inc. IMPV Stock Holding History

Sessa Capital’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-109,464
Closed -$5.08M – 24
2018
Q3 		$5.08M Hold
109,464
– – 0.66% 21
2018
Q2 		$5.28M Hold
109,464
– – 0.54% 21
2018
Q1 		$4.74M Buy
+109,464
New +$4.92M 0.5% 21

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Sessa Capital's IMPV Position: Q4 2018 in Review

Sessa Capital sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 109,464 shares — an estimated $5.08M sold.

Sessa Capital first reported a position in IMPV in Q1 2018 and held it in 3 quarters. The position peaked at $5.28M in Q2 2018. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Sessa Capital reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Sessa Capital sold 109,464 Imperva, Inc. shares in Q4 2018, an estimated $5.08M.
  • Sessa Capital first reported a position in Imperva, Inc. in Q1 2018 and held it in 3 quarters.
  • Sessa Capital's Imperva, Inc. position peaked at $5.28M in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Sessa Capital's 13F filing for Q4 2018, filed 14 Feb 2019.